Flexia Competitors

RehabCare is the leading provider of rehabilitation services, including physical, occupational and speech-language therapies, to over 2,000 hospitals and long-term care facilities in 46 states. We are the premier provider of rehab throughout the full continuum of care, including long-term acute care hospitals, nursing and rehabilitation centers, inpatient acute rehab units, independent rehabilitation facilities and hospice and home care locations.

Kinesis Corporation is the market leader in bringing the science of ergonomics to office professionals and PC gamers. Kinesis’s mission is to design and build premium ergonomic keyboards, mice and other input devices and accessories to improve both performance and comfort. Kinesis strives to provide the best possible service and products to our customers, at a fair price, and with a 60 day money-back guarantee (see website for details).

At Theralink Technologies, our approach is based on more than 16 years of research and development. Our research indicates that genomic and transcriptomic information alone provides an incomplete information resource for physicians to make patient-specific treatment decisions. Our phosphoproteomic RPPA approach is the only commercial platform that quantifies the activation state (phosphorylation) of drug target proteins and their downstream signaling partners within the tumor tissue. Our advanced technology exploits our understanding of the drug-receptor and drug-protein interactions that drive treatment responses. The Theralink assay has been developed to provide physicians with a treatment decision support tool to assist in selecting therapies that are more likely to result in responses to treatment. Our large panel of new protein biomarkers targets therapeutic molecular inhibitors including current FDA approved therapies and certain investigational drugs, making Theralink® an invaluable tool for oncologists and biopharma clinical trials.